Iris Barrera, RN Has the Following Disclosures to Make

Total Page:16

File Type:pdf, Size:1020Kb

Iris Barrera, RN Has the Following Disclosures to Make 5/20/2020 Let’s Hash out the Drug Rash Part 2 Heartland National TB Center of Excellence Presented by Nurse Consultants: Iris Barrera, Catalina Navarro, Marybel Monreal Webcast January 30, 2020 1 Iris Barrera, RN has the following disclosures to make: •No conflict of interests •No relevant financial relationships with any commercial companies pertaining to this educational activity 2 1 5/20/2020 Catalina Navarro, RN, BSN has the following disclosures to make: •No conflict of interests •No relevant financial relationships with any commercial companies pertaining to this educational activity 3 Marybel Monreal, BSN, RN has the following disclosures to make: •No conflict of interests •No relevant financial relationships with any commercial companies pertaining to this educational activity 4 2 5/20/2020 Describe the characteristics of 3 Describe common types of skin lesions. Goal: Utilize current foundational knowledge to aid Utilize dermatological terminology to Utilize patients appropriately describe skin lesions. experiencing drug rash. List List two rash identification resources. 5 But did you ask Public Health! 6 3 5/20/2020 PHYSICAL ASSESSMENT RECAP: THE COMPONENTS GATHERING OF EPISODE SPECIFIC OF A RASH INFORMATION (HISTORY.) ASSESSMENT INCLUDE: OBTAINING LABORATORY AND OTHER DATA. 7 Physical Assessment Observe the Location: Texture: Color: Red Purple patient’s reaction Arms Legs Torso Raised Flat Scaly Blanching for: Face Hands Feet Pustules Sloughing Size: Distribution: Inspect Oral Warm to the touch Pinpoint Small Diffuse Localized Mucosa Large 8 4 5/20/2020 https://patient.info/doctor/common‐childhood‐rashes# Adapted by Dr Adrian M Bonsall, from the Pediatric Handbook 6th Ed. Royal Children's Hospital, Melbourne. 9 What other Questions to ask the Are you allergic to any Any other known medication or patient: medicines? allergies? Food? remedies have you been taking? When did you first Have you been using a Any changes in your Is it: Itchy or painful? notice the reaction? different detergent? lifestyle? Gathering episode specific information 10 5 5/20/2020 How long after your dose of Drug Rash medication did the rash • Typical symptoms include redness, bumps, blisters, hives, itching, and occur (minutes, hours, days) sometimes peeling, or pain. • Every drug a person takes may have to be stopped to figure out which one is causing the rash. Has this happened before • Most drug rashes resolve once the with this medication drug is stopped, mild reactions may be treated with creams to decrease (increasing sensitivity) symptoms but serious reactions may require treatment with drugs such as epinephrine (given by injection), diphenhydramine, and/or a corticosteroid to prevent complications. Have you taken anything for the rash 11 Reference Materials • Have a visual aid available to guide your assessment and documentation For image SEARCH KEYWORD: Rash terms with pictures • Dermatology Resource: UpToDate 12 6 5/20/2020 Common Lesion Types Macules: Flat, nonpalpable lesions usually < 10 mm in diameter. Macules represent a change in color and are not raised or depressed compared to the skin surface. A patch is a large macule. Examples include freckles, flat moles, and some allergic drug eruptions Macules 13 Common Lesion Types Papules Elevated lesions usually < 10 mm in diameter that can be felt or palpated. Examples include nevi, warts, insect bites, some lesions of acne. Papules 14 7 5/20/2020 Common Lesion Types The term maculopapular is often loosely and improperly used to describe many red rashes; because this term is nonspecific and easily misused, it should be avoided. • Remember a macule is <10mm …the pictured reactions is much bigger. • Additional terms should be used • Confluent: flowing or coming *Maculopapular together also : run together. 15 Common Lesion Types • Hives AKA Urticaria AKA Wheals: • Circumscribed, raised, erythematous plaques, often with central pallor. • Lesions may be round, oval, or serpiginous( wavy margin) in shape and vary in size from less than 10mm to several centimeters in diameter. They are intensely itchy • Individual lesions are transient, usually appearing and enlarging over the course of minutes to hours and then disappearing within 24 hours. Lesions may coalesce (come together) as they Hives aka Urticaria aka enlarge. Wheals 16 8 5/20/2020 Polling Question What dermatological term best describes these non‐raised blanching erythematous skin lesions? A. Macules B. Papules C. Hives D. Maculopapular rash 17 Polling Question What dermatological term best describes these non‐raised blanching erythematous skin lesions? A. Macules B. Papules C. Hives D. Maculopapular rash 18 9 5/20/2020 Macules are flat, nonpalpable lesions usually < 10 mm in diameter. Macules represent a change in color and are not raised or depressed compared to the skin surface. Pictured is a Blanching erythematous macular rash in a patient with measles. Rationale 19 Polling Question What dermatological term best describes these raised skin lesions? A. Macules B. Papules C. Hives D. Maculopapular rash 20 10 5/20/2020 Polling Question What dermatological term best describes these raised skin lesions? A. Macules B. Papules C. Hives D. Maculopapular rash 21 Papules are elevated lesions usually < 10 mm in diameter that can be felt or palpated. Pictured are multiple hyperpigmented papules present on the face of a patient with dermatosis papulosa nigra. Rationale 22 11 5/20/2020 Polling Question What dermatological term best describes these well circumscribed, erythematous plaques that are intensely itchy? A. Macules B. Papules C. Hives D. Maculopapular rash 23 Polling Question What dermatological term best describes these well circumscribed, erythematous plaques that are intensely itchy? A. Macules B. Papules C. Hives D. Maculopapular rash 24 12 5/20/2020 Hives are circumscribed, raised, erythematous plaques, often associated with central pallor and are intensely itchy. Pictured is a urticarial drug eruption in a patient taking Moxifloxacin. Rationale 25 Summary of Common Lesions portion • A thorough physical assessment utilizing appropriate dermatological terms is critical to assisting physician recommendations and patient safety. • The term maculopapular is commonly misused and should be avoided. • Additional terms like confluent can better describe the reaction’s macular and/or papular presentation. • Remember: macules are flat discolorations and papules are elevated lesions; neither are larger than 10mm. 26 13 5/20/2020 Not all Rashes are Drug Rashes 27 “Nurse, I have a rash and I think it’s because of the medicine!” 28 14 5/20/2020 Objectives 1 Define atypical drug rashes 2 Define why some rashes are not drug rashes 3 Test your knowledge / self‐check 29 • Started anti TB therapy 3 weeks ago • Multiple erythematous papules primarily on wrist and fingers • Symptoms started 3 days ago • Itching worse at night Is this a drug rash? 30 15 5/20/2020 • Started anti TB therapy 3 weeks ago • Multiple erythematous papules primarily on wrist and fingers • Symptoms started 3 days ago • Itching worse at night Is this a drug rash? No 31 Scabies • Infestation of the skin by the burrowing mite Sarcoptes scabie • Transmitted through direct and prolonged skin‐to‐skin contact (family members or sexual partners) • Manifests as intense eruption of pruritic papules with characteristic distribution • Common sites: fingers, wrists, axillae, areolae, and genetalia 32 16 5/20/2020 Classic Scabies Burrrows Crusted Scabies • Multiple small, erythematous • Burrows are characteristic • Poorly defined, erythematous papules, often excoriated but often not visible patches that quickly develop prominent thick scale crust • Severe pruritis, worse at night • Thin, gray, red, or brown lines • Seen more in older adults or • Diffuse distribution • 2 to 15 mm in diameter immunocompromised • Back relatively free of persons involvement • Develop on scalp, hands, and • Young children & infants: feet, although any skin area palms, soles, and fingers can be affected 33 If you suspect scabies • Ask if itching is worse at night? • Ask if itching is widespread o Usually not found on the head (unless infant or young child) • Are there other household members with similar symptoms? 34 17 5/20/2020 Miliaria / • Transient cutaneious disorder caused by occlusion or Heat Rash inflammation of the eccrine sweat duct • Sweating leads to miliaria: o Hot and humid environments, physical activity, febrile illness, Miliaria/ occlusion of the skin • Can affect infants, children, and adults Heat Rash o Neonates more susceptible • Miliaria has been reported in patients treated with medications that influence the sympathetic or cholinergic systems o α‐sympathomimetic drugs: clonidine, opiates, β‐blockers 35 Crystallina Rubra Profunda • Common in neonates, usually • Erythematous papules 2 to 4 mm • Erythematous skin‐colored, firm on head neck, and upper trunk • May be papulovesicular or pustular papules 1 to 4 mm • Superficial clear vesicles 1 to 2 • Itching or stinging worsened by • Blockage deep within sweat duct that mm in diameter sweating occurs after repeated episodes of rubra • No inflammation • Common in infants in skin folds of • Common in adults, usually on trunk but • In adults common on trunk neck, axilla, or groin can be on extremities • Asymptomatic • Anhidorosis, or absence of • Can cause anhidrosis sweating, can occur in affected area • Compensatory hyperhidrosis in nonaffected area –can lead to inefficient thermoregulation 36 18 5/20/2020 Chronic inflammatory skin disease
Recommended publications
  • In Diagnosis Must Be Based on Clinical Signs and Symptoms. in This Paper
    242 POST-GRADUATE MEDICAL JOURNAL August, 1938 Postgrad Med J: first published as 10.1136/pgmj.14.154.242 on 1 August 1938. Downloaded from SOME REMARKS ON DIFFERENTIAL DIAGNOSIS OF BLOOD DISEASES. By A. PINEY, M.D., M.R.C.P. (Assistant Physician, St. Mary's Hospital for Women and Children.) Differential diagnosis of blood diseases has been discussed time and again, but, as a rule, blood-pictures, rather than clinical features, have been taken into account, so that the impression has become widespread that the whole problem is one for the laboratory, rather than for the bed-side. It is obvious, however, that the first steps in diagnosis must be based on clinical signs and symptoms. In this paper, there- fore, certain outstanding clinical features of blood diseases, and various rather puzzling syndromes will be described. The outstanding external sign that leads the practitioner to consider the possi- bility of a blood disease is pallor, which is not quite so simple a state as is often supposed. It is, of course, well known that cutaneous pallor is not an infallible sign of anaemia, but it is often presumed that well-coloured mucous membranes are fairly good evidence that anaemia is not present. This is not necessarily true. The conjunctive may be bright pink in spite of anaemia, because mild inflammationProtected by copyright. may be present, masking the pallor. This is quite frequently due to irritation by eyelash dyes. Similarly, the finger-nails, which used to serve as a reliable index of pallor, are now found disguised with coloured varnish.
    [Show full text]
  • Dermatologic Manifestations and Complications of COVID-19
    American Journal of Emergency Medicine 38 (2020) 1715–1721 Contents lists available at ScienceDirect American Journal of Emergency Medicine journal homepage: www.elsevier.com/locate/ajem Dermatologic manifestations and complications of COVID-19 Michael Gottlieb, MD a,⁎,BritLong,MDb a Department of Emergency Medicine, Rush University Medical Center, United States of America b Department of Emergency Medicine, Brooke Army Medical Center, United States of America article info abstract Article history: The novel coronavirus disease of 2019 (COVID-19) is associated with significant morbidity and mortality. While Received 9 May 2020 much of the focus has been on the cardiac and pulmonary complications, there are several important dermato- Accepted 3 June 2020 logic components that clinicians must be aware of. Available online xxxx Objective: This brief report summarizes the dermatologic manifestations and complications associated with COVID-19 with an emphasis on Emergency Medicine clinicians. Keywords: COVID-19 Discussion: Dermatologic manifestations of COVID-19 are increasingly recognized within the literature. The pri- fi SARS-CoV-2 mary etiologies include vasculitis versus direct viral involvement. There are several types of skin ndings de- Coronavirus scribed in association with COVID-19. These include maculopapular rashes, urticaria, vesicles, petechiae, Dermatology purpura, chilblains, livedo racemosa, and distal limb ischemia. While most of these dermatologic findings are Skin self-resolving, they can help increase one's suspicion for COVID-19. Emergency medicine Conclusion: It is important to be aware of the dermatologic manifestations and complications of COVID-19. Knowledge of the components is important to help identify potential COVID-19 patients and properly treat complications. © 2020 Elsevier Inc.
    [Show full text]
  • Review Cutaneous Patterns Are Often the Only Clue to a a R T I C L E Complex Underlying Vascular Pathology
    pp11 - 46 ABstract Review Cutaneous patterns are often the only clue to a A R T I C L E complex underlying vascular pathology. Reticulate pattern is probably one of the most important DERMATOLOGICAL dermatological signs of venous or arterial pathology involving the cutaneous microvasculature and its MANIFESTATIONS OF VENOUS presence may be the only sign of an important underlying pathology. Vascular malformations such DISEASE. PART II: Reticulate as cutis marmorata congenita telangiectasia, benign forms of livedo reticularis, and sinister conditions eruptions such as Sneddon’s syndrome can all present with a reticulate eruption. The literature dealing with this KUROSH PARSI MBBS, MSc (Med), FACP, FACD subject is confusing and full of inaccuracies. Terms Departments of Dermatology, St. Vincent’s Hospital & such as livedo reticularis, livedo racemosa, cutis Sydney Children’s Hospital, Sydney, Australia marmorata and retiform purpura have all been used to describe the same or entirely different conditions. To our knowledge, there are no published systematic reviews of reticulate eruptions in the medical Introduction literature. he reticulate pattern is probably one of the most This article is the second in a series of papers important dermatological signs that signifies the describing the dermatological manifestations of involvement of the underlying vascular networks venous disease. Given the wide scope of phlebology T and its overlap with many other specialties, this review and the cutaneous vasculature. It is seen in benign forms was divided into multiple instalments. We dedicated of livedo reticularis and in more sinister conditions such this instalment to demystifying the reticulate as Sneddon’s syndrome. There is considerable confusion pattern.
    [Show full text]
  • Measles Diagnostic Tool
    Measles Prodrome and Clinical evolution E Fever (mild to moderate) E Cough E Coryza E Conjunctivitis E Fever spikes as high as 105ºF Koplik’s spots Koplik’s Spots E E Viral enanthem of measles Rash E Erythematous, maculopapular rash which begins on typically starting 1-2 days before the face (often at hairline and behind ears) then spreads to neck/ the rash. Appearance is similar to “grains of salt on a wet background” upper trunk and then to lower trunk and extremities. Evolution and may become less visible as the of rash 1-3 days. Palms and soles rarely involved. maculopapular rash develops. Rash INCUBATION PERIOD Fever, STARTS on face (hairline & cough/coryza/conjunctivitis behind ears), spreads to trunk, Average 8-12 days from exposure to onset (sensitivity to light) and then to thighs/ feet of prodrome symptoms 0 (average interval between exposure to onset rash 14 day [range 7-21 days]) -4 -3 -2 -1 1234 NOT INFECTIOUS higher fever (103°-104°) during this period rash fades in same sequence it appears INFECTIOUS 4 days before rash and 4 days after rash Not Measles Rubella Varicella cervical lymphadenopathy. Highly variable but (Aka German Measles) (Aka Chickenpox) Rash E often maculopapular with Clinical manifestations E Clinical manifestations E Generally mild illness with low- Mild prodrome of fever and malaise multiforme-like lesions and grade fever, malaise, and lymph- may occur one to two days before may resemble scarlet fever. adenopathy (commonly post- rash. Possible low-grade fever. Rash often associated with painful edema hands and feet. auricular and sub-occipital).
    [Show full text]
  • Anemia in Children with Palmar Pallor Aged 02 Months to 05 Years
    eCommons@AKU Department of Paediatrics and Child Health Division of Woman and Child Health 2-28-2017 Anemia in children with palmar pallor aged 02 months to 05 years Saroop Chand Farzana Shaikh Chetan Das Yasmeen Memon Mohammad Akbar Nizamani See next page for additional authors Follow this and additional works at: https://ecommons.aku.edu/ pakistan_fhs_mc_women_childhealth_paediatr Part of the Pediatrics Commons Authors Saroop Chand, Farzana Shaikh, Chetan Das, Yasmeen Memon, Mohammad Akbar Nizamani, and Zulfiqar Ali Qutrio Baloch IAJPS 2017, 4 (02), 290-295 Zulfiqar Ali Qutrio Baloch et al ISSN 2349-7750 CODEN (USA): IAJPBB ISSN: 2349-7750 INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES http://doi.org/10.5281/zenodo.345648 Available online at: http://www.iajps.com Research Article ANEMIA IN CHILDREN WITH PALMAR PALLOR AGED 02 MONTHS TO 05 YEARS Dr. Saroop Chand1, Dr. Farzana Shaikh1, Dr. Chetan Das1, Dr. Yasmeen Memon1, Dr. Mohammad Akbar Nizamani1 and *Dr. Zulfiqar Ali Qutrio Baloch2 1Department of pediatrics Liaquat University of Medical and Health Sciences (LUMHS). 2Brandon Regional Hospital, Brandon, Florida. Received: 10 February 2016 Accepted: 25 February 2017 Published: 28 February 2017 Absract: Objective: To determine the frequency of anemia in children with palmar pallor aged 02 months to 05 years Patients and Methods: This cross sectional descriptive study of six months (01-12-2012 to 31-05-2013) was conducted in the department of paediatrics at Liaquat University Hospital Hyderabad. All the children, from 02 months to 05 years, of either gender had palmar pallor on examination were recruited and evaluated for anemia by assessing the level of haemoglobin and categorized anemia as mild, moderate and severe.
    [Show full text]
  • Cerebellar Disease in the Dog and Cat
    CEREBELLAR DISEASE IN THE DOG AND CAT: A LITERATURE REVIEW AND CLINICAL CASE STUDY (1996-1998) b y Diane Dali-An Lu BVetMed A thesis submitted for the degree of Master of Veterinary Medicine (M.V.M.) In the Faculty of Veterinary Medicine University of Glasgow Department of Veterinary Clinical Studies Division of Small Animal Clinical Studies University of Glasgow Veterinary School A p ril 1 9 9 9 © Diane Dali-An Lu 1999 ProQuest Number: 13815577 All rights reserved INFORMATION TO ALL USERS The quality of this reproduction is dependent upon the quality of the copy submitted. In the unlikely event that the author did not send a com plete manuscript and there are missing pages, these will be noted. Also, if material had to be removed, a note will indicate the deletion. uest ProQuest 13815577 Published by ProQuest LLC(2018). Copyright of the Dissertation is held by the Author. All rights reserved. This work is protected against unauthorized copying under Title 17, United States C ode Microform Edition © ProQuest LLC. ProQuest LLC. 789 East Eisenhower Parkway P.O. Box 1346 Ann Arbor, Ml 48106- 1346 GLASGOW UNIVERSITY lib ra ry ll5X C C ^ Summary SUMMARY________________________________ The aim of this thesis is to detail the history, clinical findings, ancillary investigations and, in some cases, pathological findings in 25 cases of cerebellar disease in dogs and cats which were presented to Glasgow University Veterinary School and Hospital during the period October 1996 to June 1998. Clinical findings were usually characteristic, although the signs could range from mild tremor and ataxia to severe generalised ataxia causing frequent falling over and difficulty in locomotion.
    [Show full text]
  • History & Physical Format
    History & Physical Format SUBJECTIVE (History) Identification name, address, tel.#, DOB, informant, referring provider CC (chief complaint) list of symptoms & duration. reason for seeking care HPI (history of present illness) - PQRST Provocative/palliative - precipitating/relieving Quality/quantity - character Region - location/radiation Severity - constant/intermittent Timing - onset/frequency/duration PMH (past medical /surgical history) general health, weight loss, hepatitis, rheumatic fever, mono, flu, arthritis, Ca, gout, asthma/COPD, pneumonia, thyroid dx, blood dyscrasias, ASCVD, HTN, UTIs, DM, seizures, operations, injuries, PUD/GERD, hospitalizations, psych hx Allergies Meds (Rx & OTC) SH (social history) birthplace, residence, education, occupation, marital status, ETOH, smoking, drugs, etc., sexual activity - MEN, WOMEN or BOTH CAGE Review Ever Feel Need to CUT DOWN Ever Felt ANNOYED by criticism of drinking Ever Had GUILTY Feelings Ever Taken Morning EYE OPENER FH (family history) age & cause of death of relatives' family diseases (CAD, CA, DM, psych) SUBJECTIVE (Review of Systems) skin, hair, nails - lesions, rashes, pruritis, changes in moles; change in distribution; lymph nodes - enlargement, pain bones , joints muscles - fractures, pain, stiffness, weakness, atrophy blood - anemia, bruising head - H/A, trauma, vertigo, syncope, seizures, memory eyes- visual loss, diplopia, trauma, inflammation glasses ears - deafness, tinnitis, discharge, pain nose - discharge, obstruction, epistaxis mouth - sores, gingival bleeding, teeth,
    [Show full text]
  • FDA CVM Comprehensive ADE Report Listing for Sarolaner
    CVM ADE Comprehensive Clinical Detail Report Listing Cumulative Date Range : 24-Feb-2016 -thru- 31-Jul-2018 Included 1932a cases = : True Included Medicated Feed cases = : False DRUG: SAROLANER Species: Cat Route of Administration: oral Sign: ACCIDENTAL EXPOSURE, Number of times reported: 41 Sign: SEIZURE NOS, Number of times reported: 25 Sign: VOMITING, Number of times reported: 15 Sign: TREMOR, Number of times reported: 10 Sign: HYPERSALIVATION, Number of times reported: 9 Sign: MUSCLE TREMOR, Number of times reported: 7 Sign: TWITCHING, Number of times reported: 6 Sign: LETHARGY, Number of times reported: 5 Sign: ANOREXIA, Number of times reported: 4 Sign: HIDING, Number of times reported: 4 Sign: PANTING, Number of times reported: 4 Sign: ATAXIA, Number of times reported: 3 Sign: BEHAVIOURAL DISORDER NOS, Number of times reported: 3 Sign: DROOLING, Number of times reported: 3 Sign: EMESIS, Number of times reported: 3 Sign: FOAMING AT THE MOUTH, Number of times reported: 3 Sign: HYPERAESTHESIA, Number of times reported: 3 Sign: HYPOTHERMIA, Number of times reported: 3 Sign: NOT EATING, Number of times reported: 3 Sign: SHAKING, Number of times reported: 3 Sign: ANXIETY, Number of times reported: 2 Sign: DEHYDRATION, Number of times reported: 2 Sign: HEAD TREMOR, Number of times reported: 2 Sign: HYPERPHOSPHATAEMIA, Number of times reported: 2 Sign: LATERAL RECUMBENCY, Number of times reported: 2 Sign: NEUROLOGICAL SIGNS NOS, Number of times reported: 2 Sign: ABNORMAL MOVEMENT NOS, Number of times reported: 1 Sign: ABNORMAL ULTRASOUND
    [Show full text]
  • 4 Edema in Childhood
    Kidney International, Vol. 51, Suppl. 59 (1997). pp. S-100-S-104 (1) Red Hypo Ne] Liv Edema in childhood Ma Pre Sev SATOSHI HISANO, SEUNGHOON HAHN, NANCY B. KUEMMERLE, JAMES CM. CHAN, (2) Incr. and NATALE G. DESANTO Cardi He: h Pediatric Nephrology Division, Virginia Commonwealth University's Medical College of Virginia, Richmond, Virginia, USA, and Divisione di Nefrologia Art dell' Adulto e del Bambino, Seconda Universita'degli Studi di Napoli, Naples, Italy Renal Act ACt Idiops Fan Edema in childhood. There are two types of edema: localized edema sympathetic nervous system (SNS) activity; and (3) antidiuretic Nor and generalized edema. The causes ofgeneralized edema in childhoodare hormone (ADH) release [4-6]. These forces and perhaps as yet diverse. Formation of generalizededema involves retention of sodium and Prej unidentified factors give rise to the consequential water and water in the kidney. The treatment of generalized edema depends on the (3) Incre primary etiology. Supportive nutritional and medicaltherapies are needed sodium retention, which promotes the development of edema, Allerg to prevent further edema. These and related features of edema in The sodium and water retention leads to further decreased Vascu childhood are discussed in this review. den plasma oncotic pressure, setting up a vicious cycle perpetuating dise the edema formation. The movement of water from intracellular space to interstitial space by itself also contributes to the devel­ opment of edema formation [1, 3]. Edema can be defined as the presence of excess fluid in the In contrast, the mechanism of "overfilling edema" is expanded interstitial space of the body. Edema is divided into two types, extracellular volume that results from primary renal sodium localized edema and generalized edema.
    [Show full text]
  • RASH in INFECTIOUS DISEASES of CHILDREN Andrew Bonwit, M.D
    RASH IN INFECTIOUS DISEASES OF CHILDREN Andrew Bonwit, M.D. Infectious Diseases Department of Pediatrics OBJECTIVES • Develop skills in observing and describing rashes • Recognize associations between rashes and serious diseases • Recognize rashes associated with benign conditions • Learn associations between rashes and contagious disease Descriptions • Rash • Petechiae • Exanthem • Purpura • Vesicle • Erythroderma • Bulla • Erythema • Macule • Enanthem • Papule • Eruption Period of infectivity in relation to presence of rash • VZV incubates 10 – 21 days (to 28 d if VZIG is given • Contagious from 24 - 48° before rash to crusting of all lesions • Fifth disease (parvovirus B19 infection): clinical illness & contagiousness pre-rash • Rash follows appearance of IgG; no longer contagious when rash appears • Measles incubates 7 – 10 days • Contagious from 7 – 10 days post exposure, or 1 – 2 d pre-Sx, 3 – 5 d pre- rash; to 4th day after onset of rash Associated changes in integument • Enanthems • Measles, varicella, group A streptoccus • Mucosal hyperemia • Toxin-mediated bacterial infections • Conjunctivitis/conjunctival injection • Measles, adenovirus, Kawasaki disease, SJS, toxin-mediated bacterial disease Pathophysiology of rash: epidermal disruption • Vesicles: epidermal, clear fluid, < 5 mm • Varicella • HSV • Contact dermatitis • Bullae: epidermal, serous/seropurulent, > 5 mm • Bullous impetigo • Neonatal HSV • Bullous pemphigoid • Burns • Contact dermatitis • Stevens Johnson syndrome, Toxic Epidermal Necrolysis Bacterial causes of rash
    [Show full text]
  • A Case of a 15-Month-Old with Periorbital Edema and Severe Anemia Audrey D
    A Case of a 15-Month-Old With Periorbital Edema and Severe Anemia Audrey D. Kamzan, MD, Charles A. Newcomer, MD, Laura J. Wozniak, MD, MSHS, Noah C. Federman, MD, Lydia S. Kim, MD, MPH This is the case of a previously healthy 15-month-old girl who initially abstract presented to her primary pediatrician with a 2-week history of intermittent periorbital edema. The edema had improved by the time of the visit, and a urine specimen was unable to be obtained in the clinic. A routine fingerstick demonstrated anemia to 8.8 mg/dL, so the patient was started on ferrous sulfate. She then returned to the emergency department 1 month later with severe periorbital edema and pallor but no other significant symptoms. On physical examination, she was tachycardic with striking periorbital edema and an otherwise normal physical examination. She was noted to have a severe microcytic anemia (hemoglobin of 3.9 mg/dL and mean corpuscular Mattel Children’s Hospital and University of California, Los Angeles, Los Angeles, California volume of 53.1 fL) and hypoalbuminemia (albumin of 1.9 g/dL and total protein of 3.3 g/dL). The remainder of her electrolytes and liver function test Drs Kamzan, Newcomer, and Kim conceptualized this diagnostic dilemma and drafted the initial results were within normal limits. A urinalysis was sent, which was negative manuscript; Drs Wozniak and Federman contributed for protein. Our panel of experts reviews her case to determine a unifying to drafting the initial manuscript; and all authors diagnosis for both her severe anemia and her hypoalbuminemia.
    [Show full text]
  • Blanching Rashes
    BLANCHING RASHES Facilitators Guide Author Aoife Fox (Edits by the DFTB Team) [email protected] Author Aoife Fox Duration 1-2h Facilitator level Senior trainee/ANP and above Learner level Junior trainee/Staff nurse and Senior trainee/ANP Equipment required None OUTLINE ● Pre-reading for learners ● Basics ● Case 1: Chicken Pox (15 min) ● Case 2: Roseola (15 min) ● Case 3: Scarlet fever (20 min) ● Case 4: Kawasaki disease (including advanced discussion) (25 min) ● Game ● Quiz ● 5 take home learning points PRE-READING FOR LEARNERS BMJ Best Practice - Evaluation of rash in children PEDS Cases - Viral Rashes in Children RCEM Learning - Common Childhood Exanthems American Academy of Dermatology - Viral exanthems 2 Infectious Non-infectious Blanching Blanching Staphylococcus scalded skin syndrome Sunburn Impetigo Eczema Bullous impetigo Urticaria Eczema hepeticum Atopic dermatitis Measles Acne vulgaris Glandular fever/infectious mononucleosis Ichthyosis vulgaris keratosis pilaris Hand foot and mouth disease Salmon patch Erythema infectiosum/Fifth disease Melasma Chickenpox (varicella zoster) Napkin rash Scabies Seborrhoea Tinea corporis Epidermolysis bullosa Tinea capitis Kawasaki disease Molluscum contagiosum Steven-Johnson syndrome Scarlet fever Steven-Johnson syndrome/toxic epi- Lyme disease dermal necrolysis Congenital syphilis Erythema multiforme Congenital rubella Erythema nodosum Herpes simplex Roseola (sixth disease) Non-blanching Epstein-Barr virus Port-wine stain Pityriasis rosea Henoch-Schoenlein purpura Idiopathic thrombocytopenia Acute leukaemia Haemolytic uremic syndrome Trauma Non-blanching Mechanical (e.g. coughing, vomiting – in Meningococcal rash distribution of superior vena cava) 3 BASE Key learning points Image: used with gratitude from Wikipedia.org Definitions/rash description: ● Macule: a flat area of colour change <1 cm in size (e.g., viral exanthem [such as measles and rubella], morbilliform drug eruption).
    [Show full text]